Skip to search.
 FTSE 100 Up 0.51%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
11.02 Down 0.61(5.24%) 14:38 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:11.63
Open:N/A
Bid:11.18 x 100
Ask:11.24 x 100
1y Target Est:20.06
Beta:1.08
Earnings Date:5 Mar - 9 Mar (Est.)
Day's Range:10.85 - 11.52
52wk Range:2.45 - 16.87
Volume:776,202
Avg Vol (3m):6,969,730
Market Cap:1.10b
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACHNDown 5.24%1.10b
GSKUp 0.29%115.37b
JNJUp 0.78%284.83b
RHHBYDown 0.91%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.66
Quarterly EPS Est (Dec-14) :-0.18
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-1.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback